Yonesaka K, Tanizaki J, Maenishi O, Haratani K, et al. HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer. Clin Cancer Res 2021 Dec 17. pii: 1078-0432.CCR-21-3359.
PMID: 34921025